Cite

HARVARD Citation

    Valiakhmetova, A. et al. (2020). Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2‐Year Durable Response. Oncologist. pp. e198-e202. [Online]. 
  
Back to record